SCHEMBL13870907

SCHEMBL13870907

Cc1ccc(-c2ccc3cc(C)c(C)cc3n2)cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
RAB9A P51151 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
PDGFRB P09619 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 4/20 0.39
ALPL P05186 1/20 0.39
CA9 Q16790 1/20 0.39
CTSK P43235 1/20 0.39
NQO2 P16083 1/20 0.38
TP53 P04637 3/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
POLB P06746 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13399138 0.88 NPC1 (0.46) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL13399654 0.88 NPC1 (0.46) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL13399627 0.86 NPC1 (0.47) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL13870961 0.85 NPC1 (0.44) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL13989414 0.85 NPC1 (0.50) NPC1ESR1RAB9ASMN1; SMN2KDM4E
SCHEMBL13870939 0.84 KDM4E (0.55) NPC1RAB9ASMN1; SMN2PDGFRBKDM4E
SCHEMBL13298971 0.84 CYP1A2 (0.52) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL13399145 0.82 AR (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL12313243 0.82 NPC1 (0.44) NPC1ESR1ESR2RAB9ASMN1; SMN2
SCHEMBL12313233 0.82 NPC1 (0.44) NPC1ESR1ESR2RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 NPC1 2112/4885ESR1 87/4885ESR2 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.